Karyopharm Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.About KPTI
Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A.
CEORichard A. Paulson
CEORichard A. Paulson
Employees279
Employees279
HeadquartersNewton, Massachusetts
HeadquartersNewton, Massachusetts
Founded2008
Founded2008
Employees279
Employees279
KPTI Key Statistics
Market cap52.81M
Market cap52.81M
Price-Earnings ratio-0.42
Price-Earnings ratio-0.42
Dividend yield—
Dividend yield—
Average volume64.47K
Average volume64.47K
High today$6.40
High today$6.40
Low today$6.02
Low today$6.02
Open price$6.23
Open price$6.23
Volume51.25K
Volume51.25K
52 Week high$16.95
52 Week high$16.95
52 Week low$3.51
52 Week low$3.51
KPTI News
Simply Wall St 6d
Karyopharm Therapeutics Inc. Held Back By Insufficient Growth Even After Shares Climb 65%Karyopharm Therapeutics Inc. ( ) shares have had a really impressive month, gaining 65% after a shaky period beforehand. Not all shareholders will be feeling ju...
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
33.3%
Sell
0%
People also own
Based on the portfolios of people who own KPTI. This list is generated using Robinhood data, and it’s not a recommendation.